Arch Therapeutics, Inc. Quarterly Depreciation in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Arch Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q4 2012 to Q4 2023.
  • Arch Therapeutics, Inc. Depreciation for the quarter ending December 31, 2023 was $650.000, a 1.96% decline year-over-year.
  • Arch Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2023 was $1.95K, a 36.2% decline year-over-year.
  • Arch Therapeutics, Inc. annual Depreciation for 2023 was $1.97K, a 38.5% decline from 2022.
  • Arch Therapeutics, Inc. annual Depreciation for 2022 was $3.2K, a 23.5% increase from 2021.
  • Arch Therapeutics, Inc. annual Depreciation for 2021 was $2.59K, a 62.6% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $1.95K $650 -$13 -1.96% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q3 2023 $1.97K $650 -$149 -18.6% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-15
Q2 2023 $2.12K $273 -$526 -65.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $2.64K $380 -$419 -52.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-23
Q4 2022 $3.06K $663 -$136 -17% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q3 2022 $3.2K $799 $0 0% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-15
Q2 2022 $3.2K $799 $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $3.2K $799 +$182 +29.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-23
Q4 2021 $3.01K $799 +$427 +115% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $2.59K $799 -$661 -45.3% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-28
Q2 2021 $3.25K $799 -$966 -54.7% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $4.21K $617 -$1.15K -65% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $5.36K $372 -$1.56K -80.8% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q3 2020 $6.93K $1.46K -$458 -23.9% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-17
Q2 2020 $7.38K $1.77K -$994 -36% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $8.38K $1.77K -$15 -0.84% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $8.39K $1.94K +$155 +8.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 $8.24K $1.92K +$136 +7.63% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-11
Q2 2019 $8.1K $2.76K +$1.05K +61.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-23
Q1 2019 $7.05K $1.78K +$650 +57.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $6.4K $1.78K +$1.06K +146% Oct 1, 2018 Dec 31, 2018 10-Q 2020-01-30
Q3 2018 $5.34K $1.78K +$1.12K +168% Jul 1, 2018 Sep 30, 2018 10-K 2019-11-19
Q2 2018 $4.22K $1.71K +$1.35K +377% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $2.88K $1.13K +$773 +217% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $2.1K $724 +$605 +508% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-01
Q3 2017 $1.5K $664 +$664 Jul 1, 2017 Sep 30, 2017 10-K 2018-12-18
Q2 2017 $834 $358 +$358 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $476 $357 +$357 Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q4 2016 $119 $119 +$119 Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-01
Q3 2016 $0 $0 Jul 1, 2016 Sep 30, 2016 10-K 2017-11-15
Q2 2016 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $0 Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-01
Q4 2013 $0 -$522 -100% Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-14
Q4 2012 $522 Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.